Search Results - Victoria Atkinson
- Showing 1 - 12 results of 12
-
1
Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma by Christian Mueller, Andrew Haydon, Victoria Atkinson, Prashanth Prithviraj, Frederic Triebel, Chrystelle Brignone, Adnan Khattak, Melissa Eastgate, Amitesh Roy
Published in Journal for ImmunoTherapy of Cancer (2020-10-01)Get full text
Article -
2
Protocol for implementation of the ‘AusPROM’ recommendations for elective surgery patients: a mixed-methods cohort study by Paul S Myles, Meg E Morris, Victoria Atkinson, Natasha Brusco, Jeffrey Woods, Anita Hodge, Cathy Jones, Damien Lloyd, Vincent Rovtar, Amanda Clifford
Published in BMJ Open (2021-09-01)Get full text
Article -
3
Implementing PROMS for elective surgery patients: feasibility, response rate, degree of recovery and patient acceptability by Natasha K. Brusco, Victoria Atkinson, Jeffrey Woods, Paul S. Myles, Anita Hodge, Cathy Jones, Damien Lloyd, Vincent Rovtar, Amanda M. Clifford, Meg E. Morris
Published in Journal of Patient-Reported Outcomes (2022-07-01)Get full text
Article -
4
727 Topline safety and efficacy update of SUPLEXA-101, a first-in-human, single agent study of SUPLEXA therapeutic cells in 28 patients with metastatic solid tumours by Rohit Joshi, Sharron Gargosky, Victoria Atkinson, James A Lederer, Jeffrey Goh, Vineet Kwatra, Warren Joubert, Meena Okera, Sarwan Bishnoi, Frank Borriello, Ganessan Kitchenadasse, George Nisyrios
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
5
760 Interim PK/PD, safety and efficacy data of monotherapy dose escalation of a phase 1/2 study with MDNA11 in patients with advanced solid tumors by Kim Margolin, Victoria Atkinson, Charlotte Lemech, Philippe Bedard, Przemyslaw Twardowski, Sajeve Thomas, Amy Prawira, Arash Yavari, Peter Lloyd, Warren Brenner, Rosemina Merchant, Carole Galligan, Fahar Merchant, Minh D To, Melissa Coello, Jesus Fuentes Antras, Sudhir Madduri Karanam, Matthen Mathew
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
6
Efficacy of immune checkpoint inhibitors for in-transit melanoma by Victoria Atkinson, Shahneen Sandhu, Georgina V Long, David E Gyorki, George Au-Yeung, Grant A McArthur, Euan Walpole, Mark Smithers, Alexander Menzies, Robyn Saw, Tavis Read, Julia Lai-Kwon, Lumine Na, Emilia Nan Tie, Michael Alexander Rtshiladze, James Bozzi
Published in Journal for ImmunoTherapy of Cancer (2020-05-01)Get full text
Article -
7
Rapid-access oncodermatology is associated with reduced corticosteroid use and supports continuation of anticancer therapy after treatment-related cutaneous toxicity by Yuyang Liu, MD, Samuel X. Tan, MD, PhD, Nicholas M. Muller, MD, Xiaohua Shen, MN, Celine Lee, MD, Yit Nah Lau, MD, Victoria Atkinson, MD, Rahul Ladwa, MD, MPhil, Emma-Anne Karlsen, MD, PhD, Kiarash Khosrotehrani, MD, PhD
Published in JAAD International (2026-08-01)Get full text
Article -
8
KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma by Antoni Ribas, Inge Marie Svane, Paolo Antonio Ascierto, Victoria Atkinson, Razi Ghori, Anna Maria Di Giacomo, Georgina V Long, Henrik Schmidt, Jacob Schachter, Eduard Gasal, Paola Queirolo, Michal Lotem, Michele Del Vecchio, Pier Francesco Ferrucci, Rosalie Stephens, Mahmoud Abu-Amna, Scott J Diede, Elizabeth S Croydon
Published in Journal for ImmunoTherapy of Cancer (2020-10-01)Get full text
Article -
9
778 TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs pembro alone in treatment-naïve unresectabl... by Gino K In, James Larkin, Yazan Samhouri, Marcus Butler, Victoria Atkinson, Jeffrey Chou, Juan Martin-Liberal, Patrick Terheyden, Sajeve Thomas, Wen Shi, Xiao Wu, Andrew S Poklepovic, Young Hong, Giri Sulur, Friedrich Graf Finckenstein, John B Haanen, Andrew JS Furness, Philip Lammers, Ryan H Nguyen, Idit Peretz
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
10
The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab by Domenico Mallardo, Rachel Woodford, Alexander M. Menzies, Lisa Zimmer, Andrew williamson, Egle Ramelyte, Florentia Dimitriou, Alexandre Wicky, Roslyn Wallace, Mario Mallardo, Alessio Cortellini, Alfredo Budillon, Victoria Atkinson, Shahneen Sandhu, Michielin Olivier, Reinhard Dummer, Paul Lorigan, Dirk Schadendorf, Georgina V. Long, Ester Simeone, Paolo A. Ascierto
Published in Journal of Translational Medicine (2023-10-01)Get full text
Article -
11
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial by Xiaoyu Zhang, Anthony M Joshua, Sanjeev Kaul, Scott Antonia, Robert L Ferris, Roger B Cohen, Ezio Bonvini, Jan Baughman, Victoria Atkinson, Charu Aggarwal, Nicholas Vogelzang, Osama Rahma, Mahesh Seetharam, Yanyan Lou, Anthony Tolcher, Fernanda I Arnaldez, Amy Prawira, Ralph Hauke, Vinod Ganju, Andrew Weickhardt, Dan P Zandberg, Arash Rezazadeh Kalebasty, Alex A Adjei, Ariel Birnbaum, Rosetta Cavallo, Linda Peng, Paul A Moore, Stacie M Goldberg, Nehal J Lakhani
Published in Journal for ImmunoTherapy of Cancer (2022-04-01)Get full text
Article -
12
Advanced stage melanoma during pregnancy: recommendations from a retrospective, multicentre, registry-based studyResearch in context by Jessica S.W. Borgers, Douglas B. Johnson, Elisabeth Livingstone, Dirk Schadendorf, Elizabeth I. Buchbinder, Lauren E. Haydu, Laura Gohil, William A. Robinson, Inderjit Mehmi, Omid Hamid, Michelle Ferreira, April K.S. Salama, Florentia Dimitriou, Matteo S. Carlino, Georgina V. Long, Paolo A. Ascierto, Ester Simeone, Yana G. Najjar, Geke A.P. Hospers, Jacob Choi, Sunandana Chandra, Jeffrey D. Wayne, Carlos I.R. García, Wen Xu, Céleste Lebbé, Laetitia Da-Meda, Victoria Atkinson, Meredith Mckean, Andrea Forschner, Elliot A. Asare, Antonios Daletzakis, Jolyn S. Taylor, Frédéric Amant, Katy K. Tsai, Zeynep Eroglu, John B.A.G. Haanen, Isabella C. Glitza de Oliva
Published in EClinicalMedicine (2025-11-01)Get full text
Article
